The BBC can reveal that more than a third of 26 major trials of the drug for use on Covid have serious errors or signs of potential fraud. None of the rest show convincing evidence of ivermectin's effectiveness.
Dr Kyle Sheldrick, one of the group investigating the studies, said they had not found "a single clinical trial" claiming to show that ivermectin prevented Covid deaths that did not contain "either obvious signs of fabrication or errors so critical they invalidate the study".
And related, this article discusses the Delta variant and how it is more deadly than the original virus.
Researchers have found that the Delta variant of COVID-19 is associated with higher risk of death, hospitalisation and ICU admission.
Using data from 212,326 COVID-19 cases in the Canadian province of Ontario, the study found that Delta infections were 133% deadlier than infection with the original COVID strain. Patients with Delta were also 108% more likely to be hospitalised and 235% more likely to be admitted to an intensive care unit (ICU). The increased risk was persistent after adjusting for age, sex and comorbidities.
Other variants designated as variants of concern (VOCs) by the World Health Organization – such as the Alpha, Beta and Gamma strains – were also linked to higher risks of hospitalisation, ICU admission and death. However, the most dramatic risk increases were associated with Delta infection
Ivermectin research
